Patents by Inventor Olivier Remi Barbeau

Olivier Remi Barbeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
    Publication number: 20240166612
    Abstract: The invention provides arylthioether acetamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as bacterial infections, and in inhibiting LpxA activity.
    Type: Application
    Filed: February 18, 2022
    Publication date: May 23, 2024
    Inventors: Michael Dominic RYAN, Alastair PARKES, Olivier Rémi BARBEAU, Adele FAULKNER, Maisie HOLBROW-WILSHAW, Michelle SOUTHEY, Angelo SANZONE, Christophe BOLDRON, Elise GADOULEAU, Timothy GORMAN, Kate SPEAR, Thomas Martin KRULLE, Vasileios ROUMPELAKIS, Spencer Charles Robert NAPIER
  • Fused heterocyclic compounds and their use
    Patent number: 9550764
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: January 24, 2017
    Assignee: The Institute of Cancer Research: Royal Cancer Hospital
    Inventors: Keith Jones, Matthew David Cheeseman, Spyridon Linardopoulos, Amir Faisal, Olivier Remi Barbeau, Andrew Kalusa
  • FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE
    Publication number: 20150232462
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
    Type: Application
    Filed: August 22, 2013
    Publication date: August 20, 2015
    Inventors: Keith Jones, Matthew David Cheeseman, Spyridon Linardopoulos, Amir Faisal, Olivier Remi Barbeau, Andrew Kalusa